ClinicalTrials.gg
CompletedNCT06518447Updated Jun 12, 2025

Conventional vs Digital CAD/CAM Splints for Bruxism

An interventional study of Digital occlusal splints (CAD/CAM) and Conventional occlusal splints in Bruxism, sponsored by Pontificia Universidade Católica do Rio Grande do Sul. Completed at 1 site in Brazil. Open to participants aged 20 Years to 55 Years. Per ClinicalTrials.gov, last updated 2025-06-12.

Sponsored by Pontificia Universidade Católica do Rio Grande do Sul · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
20 Years to 55 Years
Sex
All
01

Study summary

This is a randomized controlled trial with a crossover design, which intends to enroll 20 adult patients aged between 20 and 55 years with confirmed or probable sleep bruxism. Participants will be randomized to receive either a conventional stabilization splint or a CAD/CAM splint. Each patient will use one type of splint for 30 days, followed by a 15-day wash-out period, after which they will switch to the other type of splint. The study aims to compare the quality, precision, and comfort of the two types of occlusal splints. Outcomes will include manufacturing time, amount of in-mouth adjustments, adaptation, occlusal contacts, and participant satisfaction.

02

Conditions studied

  • Bruxism

Browse trials for

Keywords

  • occlusal splints
  • computer-aided design
  • bruxism
03

In context

Bruxism

151 studies on the registry are indexed under Bruxism; 39 are open to participants now.

This study's enrollment of 20 is below the median of 39 across 94 interventional studies indexed under Bruxism.

Browse Bruxism studies →

Lead sponsor

Pontificia Universidade Católica do Rio Grande do Sul is the lead sponsor of 23 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged between 20 and 55 years.
  • Probable or confirmed diagnosis of sleep bruxism.
  • No previous treatment with occlusal splints.
  • Absence of periodontal diseases and/or dental fractures.
  • Patients must have a minimum of 28 teeth.

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic diseases affecting the temporomandibular joint, such as rheumatoid arthritis, osteoarthritis, and osteoporosis.
  • Chronic users of medications that may interfere with the study results, including analgesics, anti-inflammatory drugs, anxiolytics, antidepressants, and anticonvulsants.
  • Patients with a history of temporomandibular joint surgery.
  • Pregnant or breastfeeding women.
  • Patients with severe dental misalignment or malocclusion that would affect splint fitting and evaluation.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Investigator)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Digital occlusal splints (CAD/CAM)

    Patients in this arm will receive a CAD/CAM occlusal stabilization splint created using a fully digital workflow. The process includes: 1. Digital Impression: digital scan of the mouth will be performed using a 3shape® intraoral scanner. 2. Digital Design: The scanned data will be processed using Dental Wings' DWOS® software to design the occlusal splint virtually. The design will ensure the splint follows the Michigan splint type specifications. 3. Manufacturing: The designed splint will be fabricated using a Straumann® P series rapidshape P30+ 3D printer with a specific acrylic resin, Cosmos Splint. The splint will be polished to ensure comfort and fit, while maintaining the same surface texture as the conventional splint. 4. Fitting and Adjustment: The digitally fabricated splint will be fitted and adjusted as necessary to ensure proper adaptation and occlusal contacts. An Occlusense device will be used to verify and adjust the occlusal contacts during the fitting process.

    Device: Digital occlusal splints (CAD/CAM)

  • Active comparator
    Conventional occlusal splints

    Patients in this arm will receive a conventional occlusal stabilization splint fabricated using traditional analog methods. The process includes: 1. Impression Taking: Impressions of the patient's upper and lower arches will be taken using alginate. 2. Model Preparation: The plaster models will be mounted on a semi-adjustable articulator using a centric relation occlusal record. A wax-up of the occlusal splint will be created following the Michigan splint type specifications. 3. Manufacturing: The wax-up will be processed and flasked with heat-cured acrylic resin to create the final splint. The splint will be polished similarly to the digital splint to ensure a consistent appearance and texture. 4. Fitting and Adjustment: The conventional splint will be fitted and adjusted to ensure proper adaptation and occlusal contacts. An Occlusense device will be used to verify and adjust the occlusal contacts during the fitting process.

    Device: Conventional occlusal splints

Interventions

  • DeviceDigital occlusal splints (CAD/CAM)

    Consists of occlusal stabilization intra-oral splints fabricated using a fully digital workflow, involving intraoral scanning, virtual design, and 3D printing to ensure precise fit and comfort.

    Also known as: Digital intra-oral device

  • DeviceConventional occlusal splints

    Consists of occlusal stabilization splints fabricated using traditional analog methods, including physical impressions, plaster models, and manual processing with heat-cured acrylic resin to achieve the desired occlusal arrangement.

    Also known as: Conventional intra-oral device

06

What researchers measure

Primary outcomes

  1. Number of occlusal contacts

    The number of occlusal contacts will be measured using the OccluSense® device

    Time frame: Immediately after the initial installation

Secondary outcomes

  1. Time Required for Splint Adjustment

    The time required to adjust each splint during the fitting process

    Time frame: Immediately after the initial installation and adjustment

  2. Participant satisfaction after installation

    Patients will assess their overall satisfaction with the splints using a 5-point Likert scale, with 1 meaning the lowest score of satisfaction and 5 meaning the highest score of satisfaction.

    Time frame: Immediately after the initial installation and adjustment

  3. Participant satisfaction after 30 days

    Patients will assess their overall satisfaction with the splints using a 5-point Likert scale, with 1 meaning the lowest score of satisfaction and 5 meaning the highest score of satisfaction.

    Time frame: After 30 days of use

  4. Splint comfort after installation

    Patients will assess comfort with the splints using a 5-point Likert scale, with 1 indicating the lowest level of comfort and 5 indicating the highest level of comfort.

    Time frame: Immediately after the initial installation and adjustment

  5. Splint comfort after 30 days

    Patients will assess comfort with the splints using a 5-point Likert scale, with 1 indicating the lowest level of comfort and 5 indicating the highest level of comfort.

    Time frame: After 30 days of use

  6. Splint stability after installation

    Patients will assess the stability of the splints (retention) during use using a 5-point Likert scale, with 1 indicating the lowest level of stability (frequent movement) and 5 indicating the highest level of stability (no movement).

    Time frame: Immediately after the initial installation and adjustment

  7. Splint stability after 30 days

    Patients will assess the stability of the splints (retention) during use using a 5-point Likert scale, with 1 indicating the lowest level of stability (frequent movement) and 5 indicating the highest level of stability (no movement).

    Time frame: After 30 days of use

07

Study locations

1 site
  • Faculdade de Odontologia. Pontifícia Universidade Católica do Rio Grande do Sul.
    Porto Alegre, RS 90619-900, Brazil
08

References and documents

Individual participant data

Plan to share: No — Not planned. Sharing of anonymized data may be considered under exceptional circumstances through direct contact with investigators.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2024 to primary completion in Jan 2025, 5 months.

Of 59 non-industry interventional studies with no phase under Bruxism, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 13. This study's 5 months is below that.

Counting every sponsor, half of 60 studies reached it within 7 months; a quarter within 3 and three quarters within 13.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2024
First posted
Jul 24, 2024
StartActual
Aug 1, 2024
Primary completionActual
Jan 31, 2025
CompletionActual
Jan 31, 2025
Last update
Jun 12, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 12, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06518447
Lead sponsor
Pontificia Universidade Católica do Rio Grande do Sul
Responsible party
Sponsor
First posted
Jul 24, 2024
Start date
Aug 1, 2024
Primary completion
Jan 31, 2025
Completion
Jan 31, 2025
Last update
Jun 12, 2025

Study contacts

Marcio L Grossi, PhD
study chair · Pontifícia Universidade Católica do Rio Grande do Sul

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion